身体活动的六年变化和心脏衰竭的风险:ARIC研究
Roberta Florido1,2, Lucia Kwak2, Mariana Lazo3
1Department of Medicine, Johns Hopkins Ciccarone Center for the Prevention of Heart Disease (R.F., G.G., R.S.B., C.E.N.).
Circulation
|February 2, 2018
概括
增加身体活动 (PA) 在任何水平,即使在中年,显著降低心力衰竭 (HF) 的风险. 保持推的PA提供了最大的好处,但开始或增加活动也减少了HF发病率.
科学领域:
- 心脏病学
- 预防医学
- 公共卫生
背景情况:
- 较高的体力活动 (PA) 与心力衰竭 (HF) 的风险降低有关.
- 对于PA水平的变化对HF风险的影响尚不清楚.
研究的目的:
- 研究身体活动6年变化与心力衰竭的风险之间的关联.
- 要确定增加体力活动是否会影响心力衰竭的发生率.
主要方法:
- 从社区动脉样硬化风险 (ARIC) 研究中对11,351名参与者的分析.
- 通过问卷评估和分类的体力活动 (推,中等,差).
- 考克斯回归模型用于分析19年的PA变化和随后的HF风险.
主要成果:
- 持续推的PA与最低的HF风险相关 (HR,0. 69).
- 从不良水平提高到推水平也显著降低了HF风险 (HR,0. 77).
- 在6年内,每增加1个SD的血压都与未来HF风险降低有关 (HR,0. 89).
结论:
- 保持推的体育活动是降低心力衰竭风险的最佳方式.
- 即使在中年后期,开始或增加体育活动也与心力衰竭的风险较低有关.
- 增加身体活动的策略可能对预防心力衰竭至关重要.
相关概念视频
Heart Failure II: Pathophysiology
1.0K
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.0K
Pathophysiology of Heart Failure
4.0K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
4.0K
Heart Failure I: Introduction
966
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
966
Heart Failure VI: Adjunct Therapies
402
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
402
Heart Failure Drugs: Diuretics
1.0K
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
1.0K
Heart Failure V: Medical Management
369
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
369


